✦ LIBER ✦

Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials

✍ Scribed by Xavier Castells,Ruth Cunill,Dolors Capell

Book ID: 126342250
Publisher: Springer
Year: 2012
Tongue: English
Weight: 337 KB
Volume: 69
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-012-1390-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A large, double-blind, randomized clinic

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

✍ Thomas Spencer; Joseph Biederman; Timothy Wilens; Robert Doyle; Craig Surman; Je 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Bupropion for adults with attention-defi

Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials

✍ Narong Maneeton; Benchalak Maneeton; Manit Srisurapanont; Stephen D. Martin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

A Randomized, Placebo-Controlled Trial o

A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

✍ Joseph Biederman; Eric Mick; Craig Surman; Robert Doyle; Paul Hammerness; Theres 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A controlled trial of methylphenidate in

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders

✍ Pieter J. Carpentier; Cor A. J. De Jong; Boukje A. G. Dijkstra; Cor A. G. Verbru 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Methylphenidate Hydrochloride Modified-R

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

✍ Huss, Michael; Ginsberg, Ylva; Tvedten, Torbjorn; Arngrim, Torben; Philipsen, Al 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 871 KB

Efficacy of reboxetine in adults with at

Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial

✍ Forough Riahi; Mehdi Tehrani-Doost; Zahra Shahrivar; Javad Alaghband-Rad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of